Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 2/20 | 0.76 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.75 |
| ▸ | CA2 | P00918 | 2/20 | 0.71 |
| ▸ | CA1 | P00915 | 1/20 | 0.71 |
| ▸ | GPR132 | Q9UNW8 | 1/20 | 0.66 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.65 |
| ▸ | CTSL | P07711 | 3/20 | 0.64 |
| ▸ | CTSS | P25774 | 1/20 | 0.64 |
| ▸ | CTSK | P43235 | 1/20 | 0.64 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.61 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.61 |
| ▸ | MEN1 | O00255 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.61 |
| ▸ | CTRB1 | P17538 | 3/20 | 0.61 |
| ▸ | MME | P08473 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL111236 | 1.00 | ACE (0.76) | ACEPTPN1CA2CA1GPR132 | |
| SCHEMBL528464 | 1.00 | ACE (0.76) | ACEPTPN1CA2CA1GPR132 | |
| SCHEMBL28419447 | 0.98 | ACE (0.74) | ACEPTPN1CA2CA1GPR132 | |
| SCHEMBL28419446 | 0.98 | ACE (0.74) | ACEPTPN1CA2CA1GPR132 | |
| Hydrochloric Acid SCHEMBL10622640 | 0.98 | ACE (0.74) | ACEPTPN1CA2CA1GPR132 | |
| SCHEMBL4357736 | 0.94 | ACE (0.68) | ACEPTPN1CA2CA1GPR132 | |
| SCHEMBL4356229 | 0.94 | ACE (0.68) | ACEPTPN1CA2CA1GPR132 | |
| SCHEMBL6857183 | 0.92 | PTPN1 (0.69) | ACEPTPN1CA2CA1GPR132 | |
| SCHEMBL10033681 | 0.92 | PTPN1 (0.69) | ACEPTPN1CA2CA1GPR132 | |
| SCHEMBL2632872 | 0.92 | PTPN1 (0.74) | ACEPTPN1CA2CA1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1153 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260115310-A1 | COMPOSITIONS AND METHODS FOR MAKING ANTIBODY CONJUGATES | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2026-04-30 | — | — | US | claimed |
| US-20260043807-A1 | PHOTOREACTIVE ANTIBODY-BINDING DOMAIN FOR SITE-SPECIFIC MODIFICATION OF THE ANTIGEN BINDING FRAGMENT (Fab) OF IgG AND IgM | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2026-02-12 | — | — | US | claimed |
| EP-4568987-A2 | PHOTOREACTIVE ANTIBODY-BINDING DOMAIN FOR SITE-SPECIFIC MODIFICATION OF THE ANTIGEN BINDING FRAGMENT (FAB) OF IGG AND IGM | The Trustees of The University of Pennsylvania (US) | 2025-06-18 | — | — | EP | claimed |
| US-12324842-B2 | Compositions and methods for making antibody conjugates | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2025-06-10 | — | — | US | claimed |
| US-20250130224-A1 | PHOTOREACTIVE ANTIBODY BINDING DOMAINS WITH EPITOPE TAGS FOR MULTIPLEXED ANTIBODY LABELING, DETECTION, AND PURIFICATION | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2025-04-24 | — | — | US | claimed |
| CN-119504598-A | Method for preparing azlactone self-coupling body by converting amino acid by using sulfur hexafluoride | 国网安徽省电力有限公司电力科学研究院 | 2025-02-25 | — | — | CN | claimed |
| CN-114561376-B | Method for directionally immobilizing enzyme through photocrosslinking short peptide | 天津科技大学 | 2024-09-27 | — | — | CN | claimed |
| US-20240271091-A1 | BISPECIFIC CYTOTOXIC LYMPHOCYTE OR MACROPHAGE-REDIRECTING AUTOANTIBODIES, METHODS FOR PRODUCTION THEREOF AND METHODS OF TREATMENT | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2024-08-15 | — | — | US | claimed |
| EP-4380620-A2 | PHOTOREACTIVE ANTIBODY BINDING DOMAINS WITH EPITOPE TAGS FOR MULTIPLEXED ANTIBODY LABELING, DETECTION, AND PURIFICATION | The Trustees of The University of Pennsylvania (US) | 2024-06-12 | — | — | EP | claimed |
| EP-4352074-A1 | ANTIVIRAL LARAZOTIDE DERIVATIVES | Fasano, Alessio (US) | 2024-04-17 | — | — | EP | claimed |
| EP-0784469-B1 | COMPOSITIONS FOR THE DELIVERY OF ANTIGENS | EMISPHERE TECH INC (US) | 2004-03-24 | — | — | EP | claimed |
| US-5958457-A | MIXTURES OF ANTIGENS WITH ADJUVANTS AND ACYLATED AMINO ACIDS OR SALTS, POLYMERS OR SULFONATED AMINO ACIDS | EMISPHERE TECHNOLOGIES, INC. (US) | 1999-09-28 | — | — | US | claimed |
| EP-0784469-A4 | COMPOSITIONS FOR THE DELIVERY OF ANTIGENS | EMISPHERE TECH INC (US) | 1999-03-24 | — | — | EP | claimed |
| EP-0784469-A1 | COMPOSITIONS FOR THE DELIVERY OF ANTIGENS | Emisphere Technologies, Inc. (US) | 1997-07-23 | — | — | EP | claimed |
| WO-1996012474-A1 | COMPOSITIONS FOR THE DELIVERY OF ANTIGENS | EMISPHERE TECHNOLOGIES, INC. (US) | 1996-05-02 | — | — | WO | claimed |
| US-5284872-A | Nitrato alkanoic acid derivatives, methods for their production, pharmaceutical compositions containing the derivatives and medicinal uses thereof | SCHWARZ PHARMA AG (DE) | 1994-02-08 | — | — | US | claimed |
| EP-0178911-B1 | COMPOSITION CONTAINING A PENEM OR CARBAPENEM ANTIBIOTIC | SANKYO COMPANY LIMITED (JP) | 1992-01-22 | — | — | EP | claimed |
| US-4762881-A | Photoreactive benzoylphenylalanines and related peptides | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1988-08-09 | — | — | US | claimed |
| US-4757066-A | Reduces renal toxicity | SANKYO COMPANY LIMITED (JP) | 1988-07-12 | — | — | US | claimed |
| EP-0178911-A2 | Composition containing a penem or carbapenem antibiotic | SANKYO COMPANY LIMITED (JP) | 1986-04-23 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260043807-A1 | PHOTOREACTIVE ANTIBODY-BINDING DOMAIN FOR SITE-SPECIFIC MODIFICATION OF THE ANTIGEN BINDING FRAGMENT (Fab) OF IgG AND IgM | IGSF11, CD22, IGLV6-57 | ACE 3268/4885PTPN1 1331/4885CA2 4213/4885 |
| US-20260115310-A1 | COMPOSITIONS AND METHODS FOR MAKING ANTIBODY CONJUGATES | CD4, STAMBP, VSIG8 | ACE 4011/4885PTPN1 565/4885CA2 4263/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.